⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

AGIO

Agios Pharmaceuticals, Inc.

Healthcare · Biotechnology

37.00USD

-0.1900 (-0.51%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on AGIO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY14.2M26.8M36.5M54.0M176.7M345.4M
Q1832.0K5.6M8.2M8.7M20.7M—
Q25.6M6.7M8.6M12.5M44.7M—
Q33.5M7.4M9.0M12.9M51.5M—
Q44.3M*7.1M*10.7M*20.0M*59.7M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-4.23-6.3311.64-7.12-5.74-3.77
Q1-1.74-1.47-1.45-1.55-1.69—
Q2-1.68-1.51-1.69-1.93-1.69—
Q3-1.49-1.6416.22-1.78-1.23—
Q4.667*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

3)

Revenue to Profit Conversion

Revenue to net income

 

 

QuarterlyAnnual
Level
-1.72*
-1.67*
-1.86*
-1.14
—
4)

Debt Level and Coverage

Debt level and coverage

 

 

QuarterlyAnnual
Debt